StockData

Claritev vs HealthEquity

CTEV and HQY side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CTEV and HQY compare

HealthEquity is the larger company, worth 22 times as much as Claritev ($8.4B against $389M).

HealthEquity grew revenue faster over the last twelve months (7.3% versus 6.3% for Claritev).

HealthEquity keeps more of each dollar of sales as profit, with a net margin of 17.4% compared with −28.5% at Claritev.

HealthEquity scores higher on the StockData Score (15 against 3 for Claritev), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCTEVHQY
Size and price
Market cap$389M$8.4B
Share price$22.95$101.84
Change, 1 year−46.9%0.07%
Change, 5 years−86.8%77.5%
Beta (5Y)3.400.39
Employees3,0002,814
StockData Score
Total score315 (better)
Valuation score13 (better)
Growth score13 (better)
Performance score14 (better)
Health score05 (better)
Dividend score00
Valuation
P/E–36.8×
P/S0.4× (better)6.2×
P/B–4.2×
EV/EBITDA153×17.9× (better)
P/FCF–17.3×
FCF yield−4.6%5.8% (better)
Fair value–$110.02
Margin of safety–7.4%
Growth
Revenue growth (TTM)6.3%7.3% (better)
Revenue growth, 5Y average0.58%12.4% (better)
Net income growth (TTM)–62.2%
EPS growth (TTM)–67.9%
EPS growth, 5Y average–83.0%
Profitability
Gross margin73.0% (better)71.2%
Operating margin3.3%25.8% (better)
Net margin−28.5%17.4% (better)
FCF margin−1.8%35.8% (better)
Return on equity–11.4%
Return on invested capital0.59%9.8% (better)
Financial health
Debt / equity–0.47
Net debt / EBITDA141.211.33 (better)
Interest coverage0.1×6.7× (better)
Current ratio1.002.99 (better)
Altman Z-score−0.484.90 (better)
Piotroski F-score59 (better)
Dividends and buybacks
Buyback yield−0.51%4.8% (better)
Shareholder yield−0.51%4.8% (better)
Ownership
Held by institutions91.0%109%
Held by insiders51.8%1.4%
Insider net buying, 12 months$8.9M (better)−$4.1M
Short interest, % of float9.4%6.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.